In a published model-based cost-effectiveness analysis of screening for Lynch Syndrome in people with colorectal cancer, the estimated unit cost for IHC was £210 and £202 for MSI and £136 per test for MLH1 hypermethylation. This evidence concerns the gene MLH1 and colorectal cancer.